Evidence map›Paper›PMID 30093628›Full record

ArticleOncogene2019

Transcriptomic analysis of CIC and ATXN1L reveal a functional relationship exploited by cancer.

Derek Wong, Kohl Lounsbury, Amy Lum, Jungeun Song, Susanna Chan, Veronique LeBlanc, Suganthi Chittaranjan, Marco Marra, Stephen Yip

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 52 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. TheeLife · 2022
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Capicua in Human Cancer.Trends in cancer · 2021
    Review
  19. Article
  20. Negative MAPK-ERK regulation sustains CIC-DUX4 oncoprotein expression in undifferentiated sarcoma.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Derek WongPathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.ORCID http://orcid.org/0000-0003-2607-5265
Kohl LounsburyCellular and Physiological Sciences, University of British Columbia, Vancouver, Canada.
Amy LumMolecular Oncology, BC Cancer, Vancouver, Canada.
Jungeun SongCanada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada.
Susanna ChanCanada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada.
Veronique LeBlancCanada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada.
Suganthi ChittaranjanCanada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada.
Marco MarraCanada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada.
Stephen YipPathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada. Stephen.Yip@vch.ca.
Canada's Michael Smith Genome Sciences Centre · CAUniversity of British Columbia · CA

Funding

Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) FDN-143288Provincial Health Services Authority, British Columbia | BC Cancer Agency (British Columbia Cancer Agency) 1BNRG009Provincial Health Services Authority (Provincial Health Services Authority, British Columbia) 1BNRG009
6 · The paper itself

Abstract

Aberrations in Capicua (CIC) have recently been implicated as a negative prognostic factor in a multitude of cancer types through activation of the MAPK signalling cascade and derepression of oncogenic ETS transcription factors. The Ataxin-family protein ATXN1L has previously been reported to interact with CIC in developmental and disease contexts to facilitate the repression of CIC target genes. To further investigate this relationship, we performed functional in vitro studies utilizing ATXN1L

Indexed as

Ataxin-1Cell CycleCell Line, TumorGene Expression ProfilingHumansNeoplasmsRepressor ProteinsAtaxin-1ATXN1L protein, humanATXN1 protein, humanCIC protein, humanRepressor Proteins

Identifiers

PMID30093628
OpenAlexW2886939149

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.